1-4 of 4
Alexandra G. Smith
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report

Stuart E. Lacy, Sharon L. Barrans, Philip A. Beer, Daniel Painter, Alexandra G. Smith, Eve Roman, Susanna L. Cooke, Camilo Ruiz, Paul Glover, Suzan J. L. Van Hoppe, Nichola Webster, Peter J. Campbell, Reuben M. Tooze, Russell Patmore, Cathy Burton, Simon Crouch, Daniel J. Hodson
Journal: Blood
Blood (2020) 135 (20): 1759–1771.
https://doi.org/10.1182/blood.2019003535
Published: 2020
Includes: Supplemental data
Journal Articles

Novel Targeted Therapies and Their Impact on Survival from Multiple Myeloma (MM) and Chronic Lymphocytic Leukaemia (CLL) in the Real World

Alexandra G Smith, PhD, Timothy Bagguley, MSc, Eve Roman, PhD, Andy C Rawstron, James R Bailey, MA MBBS MRCP, Debra Howell, PhD, John Ashcroft, MD MBBChir, PhD MRCP, MA, FRCPath, Burton Cathy, Gordon Cook, MD PhD, Russell Patmore, MRCP FRCPath
Journal: Blood
Blood (2016) 128 (22): 3546.
https://doi.org/10.1182/blood.V128.22.3546.3546
Published: 2016
Journal Articles

A common genetic variant in XPD associates with risk of 5q- and 7q-deleted acute myeloid leukemia

Brief Report
Alexandra G. Smith, Lisa J. Worrillow, James M. Allan
Journal: Blood
Blood (2006) 109 (3): 1233–1236.
https://doi.org/10.1182/blood-2006-07-037853
Published: 2006
Journal Articles

Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy

Clinical Trials & Observations
James M. Allan, Alexandra G. Smith, Keith Wheatley, Robert K. Hills, Lois B. Travis, Deirdre A. Hill, David M. Swirsky, Gareth J. Morgan, Christopher P. Wild
Journal: Blood
Blood (2004) 104 (13): 3872–3877.
https://doi.org/10.1182/blood-2004-06-2161
Published: 2004